Platelet aggregation is a fundamental biological phenomenon critical for the maintenance of vascular health and the prevention of excessive bleeding. This intricate process involves the binding of platelets to exposed collagen at the site of vascular injury, initiating a series of events that culminate in the formation of a blood clot. The activated platelets release chemical signals, recruiting and activating additional platelets to amplify the response. This orchestrated cascade of platelet activation is pivotal for hemostasis, ensuring the swift formation of a protective clot to seal any breaches in blood vessels. The plug formed by aggregated platelets is indispensable for preventing prolonged bleeding and facilitating wound healing. However, deviations from the finely tuned regulation of platelet aggregation can lead to detrimental outcomes, such as thrombosis, where excessive clotting occurs within blood vessels.
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, Tianjin University, China
Title : Not So Idiopathic After All: Genotype, Phenotype and IL-1 Blockade Response Converge in Recurrent Pericarditis
burcu yagmur, Kyrenia University Hospital, Cyprus
Title : Beyond the Heart in Cardiovascular Magnetic Resonance Imaging: Prevalence and Clinical Significance of Incidental Extracardiac Findings
burcu yagmur, Kyrenia University Hospital, Cyprus
Title : Cardiovascular mortality in colon cancer a patient characteristics analysis: Population-based study
Nouf, KAU, Saudi Arabia
Title : Improving Screening and Treatment of Iron Deficiency in Patients with Heart Failure with Reduced Ejection Fraction: A Two-Cycle Quality Improvement Project
Danish Malik, University Hospitals Dorset NHS Foundation Trust, United Kingdom